Effect of carvedilol on atrioventricular conduction in the ischemic heart

European Journal of Pharmacology

Volumn 412, Issue 2, 2001, Pages 145-153

  Horio, Toru ^a   Ito, Shigenori ^a   Aoyama, Michihiko ^b   Takeda, Yutaka ^a   Suzumura, Hiroshi ^a   Nakata, Koutarou ^c   Yamada, Yoshiaki ^a   Suzuki, Shogo ^a   Fukutomi, Tatsuya ^a   Itoh, Makoto ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Inabe General Hospital   (Japan)

^c Nagoya City Midori General Hospital   (Japan)

Author keywords

Adrenoceptor antagonist; Atrioventricular conduction; Carvedilol; Ischemia reperfusion; Propranolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; PRAZOSIN; PROPRANOLOL; RINGER SOLUTION;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; GUINEA PIG; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART MUSCLE REPERFUSION; HEART PAPILLARY MUSCLE; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ACTION POTENTIALS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BUNDLE OF HIS; CARBAZOLES; GUINEA PIGS; MALE; MYOCARDIAL ISCHEMIA; PAPILLARY MUSCLES; PRAZOSIN; PROPANOLAMINES; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 0035951659     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00936-5     Document Type: Article

References (24)

1. Cardioprotective effects of carvedilol, a novel β drenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: Comparison with propranolol
2. Receptor pharmacology of carvedilol in the human heart
3. Effects of concentration and steric configuration of propranolol on AV conduction and ventricular repolarization in the dog
4. The acute electrophysiological effects of intravenous metoprolol
5. Effect of selective and non-selective beta-adrenergic receptors blockade on selected electrophysiological properties of the human heart
6. Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog
7. Electrophysiological effects of high-dose propranolol in dogs: Evidence in vivo for effects not mediated by the beta adrenoceptor
8. The relevance of β-receptor blockade to ouabain-induced cardiac arrhythmias
9. Myocardial protection with carvedilol
10. Pharmacokinetics of carvedilol(DQ-2466) in healthy subjects
11. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses
12. Electrophysiological effects of cardioselective and non-cardioselective β-adrenoceptor blockers with and without ISA at rest and during exercise
13. Comparative dromotropic activity of timolol and propranolol in anesthetized dogs
14. Electrophysiologic effects of propranolol in intraventricular conduction disturbance
15. Electrophysiologic effects of intravenous metoprolol
16. Effects of beta receptor stimulation and blockade on A-V nodal and bundle branch conduction in the canine heart
17. Electrophysiological properties of intravenous metoprolol in man
18. Clinical electrophysiological effects of atenolol - A new cardioselective beta-blocking agent
19. The electrophysiology of propranolol in man
20. UK-52,046 (a novel α1-adrenoceptor antagonist) and the role of α-adrenoceptor stimulation and blockade on atrioventricular conduction
21. The effects of the propranolol enantiomers on the intracardiac electrophysiological activities of Langendorff perfused hearts
22. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine
23. Electrophysiology and pharmacology of cardiac arrhythmias: IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part A
24. Electrophysiology and pharmacology of cardiac arrhythmias: IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part C